We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase I Trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a Children's Oncology Group Study.
- Authors
Rheingold, Susan R; Hogarty, Michael D; Blaney, Susan M; Zwiebel, James A; Sauk-Schubert, Calies; Chandula, Reddy; Krailo, Mark D; Adamson, Peter C; Children's Oncology Group Study
- Abstract
To determine the maximum-tolerated dose, toxicity, pharmacokinetics, and biologic effects of G3139 when administered with doxorubicin and cyclophosphamide to children with relapsed solid tumors.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Vol 25, Issue 12, p1512
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2006.09.5125